Mahimbo, Abela
Tiwari, Preeti
Abdi, Ikram
Seale, Holly
Charania, Nadia
Heywood, Anita E.
Funding for this research was provided by:
GlaxoSmithKline Australia
Health Research Council of New Zealand (18/586)
Article History
Received: 28 May 2023
Accepted: 2 October 2023
First Online: 11 October 2023
Declarations
:
: Not applicable.
: Not applicable.
: A/Prof Anita Elizabeth Heywood has received honoraria from MSD (2022) and Pfizer (2021) unrelated to this manuscript. A/Prof Holly Seale has received funding from drug companies for investigator-driven research and consulting fees to present at conferences/workshops and develop resources (bio-CSL/Sequiris, GSK and Sanofi Pasteur). Dr Abela Mahimbo, Dr Preeti Tiwari, Dr Ikram Abdi, and Dr Nadia Charania have no conflicts to declare.